Dataset Information

Multi-ancestry genome-wide gene-smoking interaction study of 387,272 individuals identifies new loci associated with serum lipids.

ABSTRACT: The concentrations of high- and low-density-lipoprotein cholesterol and triglycerides are influenced by smoking, but it is unknown whether genetic associations with lipids may be modified by smoking. We conducted a multi-ancestry genome-wide gene-smoking interaction study in 133,805 individuals with follow-up in an additional 253,467 individuals. Combined meta-analyses identified 13 new loci associated with lipids, some of which were detected only because association differed by smoking status. Additionally, we demonstrate the importance of including diverse populations, particularly in studies of interactions with lifestyle factors, where genomic and lifestyle differences by ancestry may contribute to novel findings.

SUBMITTER: Bentley AR

PROVIDER: S-EPMC6467258 | biostudies-literature | 2019 Apr

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

Multi-ancestry genome-wide gene-smoking interaction study of 387,272 individuals identifies new loci associated with serum lipids.

Bentley Amy R AR Sung Yun J YJ Brown Michael R MR Winkler Thomas W TW Kraja Aldi T AT Ntalla Ioanna I Schwander Karen K Chasman Daniel I DI Lim Elise E Deng Xuan X Guo Xiuqing X Liu Jingmin J Lu Yingchang Y Cheng Ching-Yu CY Sim Xueling X Vojinovic Dina D Huffman Jennifer E JE Musani Solomon K SK Li Changwei C Feitosa Mary F MF Richard Melissa A MA Noordam Raymond R Baker Jenna J Chen Guanjie G Aschard Hugues H Bartz Traci M TM Ding Jingzhong J Dorajoo Rajkumar R Manning Alisa K AK Rankinen Tuomo T Smith Albert V AV Tajuddin Salman M SM Zhao Wei W Graff Mariaelisa M Alver Maris M Boissel Mathilde M Chai Jin Fang JF Chen Xu X Divers Jasmin J Evangelou Evangelos E Gao Chuan C Goel Anuj A Hagemeijer Yanick Y Harris Sarah E SE Hartwig Fernando P FP He Meian M Horimoto Andrea R V R ARVR Hsu Fang-Chi FC Hung Yi-Jen YJ Jackson Anne U AU Kasturiratne Anuradhani A Komulainen Pirjo P Kühnel Brigitte B Leander Karin K Lin Keng-Hung KH Luan Jian'an J Lyytikäinen Leo-Pekka LP Matoba Nana N Nolte Ilja M IM Pietzner Maik M Prins Bram B Riaz Muhammad M Robino Antonietta A Said M Abdullah MA Schupf Nicole N Scott Robert A RA Sofer Tamar T Stancáková Alena A Takeuchi Fumihiko F Tayo Bamidele O BO van der Most Peter J PJ Varga Tibor V TV Wang Tzung-Dau TD Wang Yajuan Y Ware Erin B EB Wen Wanqing W Xiang Yong-Bing YB Yanek Lisa R LR Zhang Weihua W Zhao Jing Hua JH Adeyemo Adebowale A Afaq Saima S Amin Najaf N Amini Marzyeh M Arking Dan E DE Arzumanyan Zorayr Z Aung Tin T Ballantyne Christie C Barr R Graham RG Bielak Lawrence F LF Boerwinkle Eric E Bottinger Erwin P EP Broeckel Ulrich U Brown Morris M Cade Brian E BE Campbell Archie A Canouil Mickaël M Charumathi Sabanayagam S Chen Yii-Der Ida YI Christensen Kaare K Concas Maria Pina MP Connell John M JM de las Fuentes Lisa L de Silva H Janaka HJ de Vries Paul S PS Doumatey Ayo A Duan Qing Q Eaton Charles B CB Eppinga Ruben N RN Faul Jessica D JD Floyd James S JS Forouhi Nita G NG Forrester Terrence T Friedlander Yechiel Y Gandin Ilaria I Gao He H Ghanbari Mohsen M Gharib Sina A SA Gigante Bruna B Giulianini Franco F Grabe Hans J HJ Gu C Charles CC Harris Tamara B TB Heikkinen Sami S Heng Chew-Kiat CK Hirata Makoto M Hixson James E JE Ikram M Arfan MA Jia Yucheng Y Joehanes Roby R Johnson Craig C Jonas Jost Bruno JB Justice Anne E AE Katsuya Tomohiro T Khor Chiea Chuen CC Kilpeläinen Tuomas O TO Koh Woon-Puay WP Kolcic Ivana I Kooperberg Charles C Krieger Jose E JE Kritchevsky Stephen B SB Kubo Michiaki M Kuusisto Johanna J Lakka Timo A TA Langefeld Carl D CD Langenberg Claudia C Launer Lenore J LJ Lehne Benjamin B Lewis Cora E CE Li Yize Y Liang Jingjing J Lin Shiow S Liu Ching-Ti CT Liu Jianjun J Liu Kiang K Loh Marie M Lohman Kurt K KK Louie Tin T Luzzi Anna A Mägi Reedik R Mahajan Anubha A Manichaikul Ani W AW McKenzie Colin A CA Meitinger Thomas T Metspalu Andres A Milaneschi Yuri Y Milani Lili L Mohlke Karen L KL Momozawa Yukihide Y Morris Andrew P AP Murray Alison D AD Nalls Mike A MA Nauck Matthias M Nelson Christopher P CP North Kari E KE O'Connell Jeffrey R JR Palmer Nicholette D ND Papanicolau George J GJ Pedersen Nancy L NL Peters Annette A Peyser Patricia A PA Polasek Ozren O Poulter Neil N Raitakari Olli T OT Reiner Alex P AP Renström Frida F Rice Treva K TK Rich Stephen S SS Robinson Jennifer G JG Rose Lynda M LM Rosendaal Frits R FR Rudan Igor I Schmidt Carsten O CO Schreiner Pamela J PJ Scott William R WR Sever Peter P Shi Yuan Y Sidney Stephen S Sims Mario M Smith Jennifer A JA Snieder Harold H Starr John M JM Strauch Konstantin K Stringham Heather M HM Tan Nicholas Y Q NYQ Tang Hua H Taylor Kent D KD Teo Yik Ying YY Tham Yih Chung YC Tiemeier Henning H Turner Stephen T ST Uitterlinden André G AG van Heemst Diana D Waldenberger Melanie M Wang Heming H Wang Lan L Wang Lihua L Wei Wen Bin WB Williams Christine A CA Wilson Gregory G Wojczynski Mary K MK Yao Jie J Young Kristin K Yu Caizheng C Yuan Jian-Min JM Zhou Jie J Zonderman Alan B AB Becker Diane M DM Boehnke Michael M Bowden Donald W DW Chambers John C JC Cooper Richard S RS de Faire Ulf U Deary Ian J IJ Elliott Paul P Esko Tõnu T Farrall Martin M Franks Paul W PW Freedman Barry I BI Froguel Philippe P Gasparini Paolo P Gieger Christian C Horta Bernardo L BL Juang Jyh-Ming Jimmy JJ Kamatani Yoichiro Y Kammerer Candace M CM Kato Norihiro N Kooner Jaspal S JS Laakso Markku M Laurie Cathy C CC Lee I-Te IT Lehtimäki Terho T Magnusson Patrik K E PKE Oldehinkel Albertine J AJ Penninx Brenda W J H BWJH Pereira Alexandre C AC Rauramaa Rainer R Redline Susan S Samani Nilesh J NJ Scott James J Shu Xiao-Ou XO van der Harst Pim P Wagenknecht Lynne E LE Wang Jun-Sing JS Wang Ya Xing YX Wareham Nicholas J NJ Watkins Hugh H Weir David R DR Wickremasinghe Ananda R AR Wu Tangchun T Zeggini Eleftheria E Zheng Wei W Bouchard Claude C Evans Michele K MK Gudnason Vilmundur V Kardia Sharon L R SLR Liu Yongmei Y Psaty Bruce M BM Ridker Paul M PM van Dam Rob M RM Mook-Kanamori Dennis O DO Fornage Myriam M Province Michael A MA Kelly Tanika N TN Fox Ervin R ER Hayward Caroline C van Duijn Cornelia M CM Tai E Shyong ES Wong Tien Yin TY Loos Ruth J F RJF Franceschini Nora N Rotter Jerome I JI Zhu Xiaofeng X Bierut Laura J LJ Gauderman W James WJ Rice Kenneth K Munroe Patricia B PB Morrison Alanna C AC Rao Dabeeru C DC Rotimi Charles N CN Cupples L Adrienne LA

Nature genetics 20190329 4

The concentrations of high- and low-density-lipoprotein cholesterol and triglycerides are influenced by smoking, but it is unknown whether genetic associations with lipids may be modified by smoking. We conducted a multi-ancestry genome-wide gene-smoking interaction study in 133,805 individuals with follow-up in an additional 253,467 individuals. Combined meta-analyses identified 13 new loci associated with lipids, some of which were detected only because association differed by smoking status. ...[more]

PMID: 30926973

Similar Datasets

Project description:ObjectiveSerum uric acid is the end-product of purine metabolism and at high levels is a risk factor for several human diseases including gout and cardiovascular disease. Heritability estimates range from 0.32 to 0.63. Genome-wide association studies (GWAS) provide an unbiased approach to identify loci influencing serum uric acid. Here, we performed the first GWAS for serum uric acid in continental Africans, with replication in African Americans.MethodsAfricans (n = 4126) and African Americans (n = 5007) were genotyped on high-density GWAS arrays. Efficient mixed model association, a variance component approach, was used to perform association testing for a total of ~ 18 million autosomal genotyped and imputed variants. CAVIARBF was used to fine map significant regions.ResultsWe identified two genome-wide significant loci: 4p16.1 (SLC2A9) and 11q13.1 (SLC22A12). At SLC2A9, the most strongly associated SNP was rs7683856 (P = 1.60 × 10-44). Conditional analysis revealed a second signal indexed by rs6838021 (P = 5.75 × 10-17). Gene expression and regulatory motif data prioritized a single-candidate causal variant for each signal. At SLC22A12, the most strongly associated SNP was rs147647315 (P = 6.65 × 10-25). Conditional analysis and functional annotation prioritized the missense variant rs147647315 (R (Arg) > H (His)) as the sole causal variant. Functional annotation of these three signals implicated processes in skeletal muscle, subcutaneous adipose tissue and the kidneys, respectively.ConclusionsThis first GWAS of serum uric acid in continental Africans identified three associations at two loci, SLC2A9 and SLC22A12. The combination of weak linkage disequilibrium in Africans and functional annotation led to the identification of candidate causal SNPs for all three signals. Each candidate causal variant implicated a different cell type. Collectively, the three associations accounted for 4.3% of the variance of serum uric acid.

Project description:Despite the large toll of opioid use disorder (OUD), genome-wide association studies (GWAS) of OUD to date have yielded few susceptibility loci. We performed a large-scale GWAS of OUD in individuals of European (EUR) and African (AFR) ancestry, optimizing genetic informativeness by performing MTAG (Multi-trait analysis of GWAS) with genetically correlated substance use disorders (SUDs). Meta-analysis included seven cohorts: the Million Veteran Program, Psychiatric Genomics Consortium, iPSYCH, FinnGen, Partners Biobank, BioVU, and Yale-Penn 3, resulting in a total N = 639,063 (Ncases = 20,686;Neffective = 77,026) across ancestries. OUD cases were defined as having a lifetime OUD diagnosis, and controls as anyone not known to meet OUD criteria. We estimated SNP-heritability (h2SNP) and genetic correlations (rg). Based on genetic correlation, we performed MTAG on OUD, alcohol use disorder (AUD), and cannabis use disorder (CanUD). A leave-one-out polygenic risk score (PRS) analysis was performed to compare OUD and OUD-MTAG PRS as predictors of OUD case status in Yale-Penn 3. The EUR meta-analysis identified three genome-wide significant (GWS; p ≤ 5 × 10-8) lead SNPs-one at FURIN (rs11372849; p = 9.54 × 10-10) and two OPRM1 variants (rs1799971, p = 4.92 × 10-09; rs79704991, p = 1.11 × 10-08; r2 = 0.02). Rs1799971 (p = 4.91 × 10-08) and another OPRM1 variant (rs9478500; p = 1.95 × 10-08; r2 = 0.03) were identified in the cross-ancestry meta-analysis. Estimated h2SNP was 12.75%, with strong rg with CanUD (rg = 0.82; p = 1.14 × 10-47) and AUD (rg = 0.77; p = 6.36 × 10-78). The OUD-MTAG resulted in a GWAS Nequivalent = 128,748 and 18 independent GWS loci, some mapping to genes or gene regions that have previously been associated with psychiatric or addiction phenotypes. The OUD-MTAG PRS accounted for 3.81% of OUD variance (beta = 0.61;s.e. = 0.066; p = 2.00 × 10-16) compared to 2.41% (beta = 0.45; s.e. = 0.058; p = 2.90 × 10-13) explained by the OUD PRS. The current study identified OUD variant associations at OPRM1, single variant associations with FURIN, and 18 GWS associations in the OUD-MTAG. The genetic architecture of OUD is likely influenced by both OUD-specific loci and loci shared across SUDs.

Project description:Abstract Population stratification, or systematic differences in allele frequencies between subpopulations, can distort the results from genome-wide association studies (GWAS). While GWAS are usually conducted within continental (e.g. European) ancestry groups, sub-groups may have specific population histories that result in enrichment for risk or protective alleles for complex disease. In this analysis, we examined genetic risk for glioma in a US population with predominantly Ashkenazi Jewish (AJ) ancestry. Genotyping data were obtained from three prior glioma case-control studies. Best-guess assignment to one of seven subcontinental European ancestry groups was performed using AIPS (https://github.com/biomedicaldatascience/AIPS). Out of a total of 6,416 cases and 7,441 controls across all three studies, 202 cases (3% of all cases, 63% GBM) and 403 controls (5% of all controls) were assigned to the AJ ancestry group. Unconditional logistic regression was performed for by study (adjusted for age and first two principal components) and then studies were combined using fixed effects meta-analysis. No associations reached genome-wide significance (p< 5x10-8), including those detected in prior pan-European GWAS. A nominally significant association was detected on chromosome 17 in ASPA (rs9904040, MAF=20%, p=2.61x10-6, Odds ratio=2.22 [95% confidence interval=1.59–3.09]) which is in linkage equilibrium (r2=0.0013) with the previously detected glioma risk SNP in TP53 (MAF=0.3% in this analysis, p=0.8801) in the European population. In our prior pan-European meta-analysis (Melin et al., 2017, this SNP was non-significant (p=0.0620). This study failed to replicate many previously identified glioma risk alleles, likely due to diminished power due to small sample size. We did identify a novel risk allele on chromosome 17 in ASPA, which encodes for aspartoacylase (which catalyzes deacylation of N-acetyl_L-aspartic acid). Larger sample sizes identified via targeted recruitment are necessary in order to fully characterize genetic risk for glioma in this population, including assessment of rare (MAF< 5%) risk allele associations.

Project description:Back pain is the #1 cause of years lived with disability worldwide, yet surprisingly little is known regarding the biology underlying this symptom. We conducted a genome-wide association study (GWAS) meta-analysis of chronic back pain (CBP). Adults of European ancestry were included from 15 cohorts in the Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) consortium, and from the UK Biobank interim data release. CBP cases were defined as those reporting back pain present for ≥3-6 months; non-cases were included as comparisons ("controls"). Each cohort conducted genotyping using commercially available arrays followed by imputation. GWAS used logistic regression models with additive genetic effects, adjusting for age, sex, study-specific covariates, and population substructure. The threshold for genome-wide significance in the fixed-effect inverse-variance weighted meta-analysis was p<5×10(-8). Suggestive (p<5×10(-7)) and genome-wide significant (p<5×10(-8)) variants were carried forward for replication or further investigation in the remaining UK Biobank participants not included in the discovery sample. The discovery sample comprised 158,025 individuals, including 29,531 CBP cases. A genome-wide significant association was found for the intronic variant rs12310519 in SOX5 (OR 1.08, p = 7.2×10(-10)). This was subsequently replicated in 283,752 UK Biobank participants not included in the discovery sample, including 50,915 cases (OR 1.06, p = 5.3×10(-11)), and exceeded genome-wide significance in joint meta-analysis (OR 1.07, p = 4.5×10(-19)). We found suggestive associations at three other loci in the discovery sample, two of which exceeded genome-wide significance in joint meta-analysis: an intergenic variant, rs7833174, located between CCDC26 and GSDMC (OR 1.05, p = 4.4×10(-13)), and an intronic variant, rs4384683, in DCC (OR 0.97, p = 2.4×10(-10)). In this first reported meta-analysis of GWAS for CBP, we identified and replicated a genetic locus associated with CBP (SOX5). We also identified 2 other loci that reached genome-wide significance in a 2-stage joint meta-analysis (CCDC26/GSDMC and DCC).

Dataset Information

Multi-ancestry genome-wide gene-smoking interaction study of 387,272 individuals identifies new loci associated with serum lipids.

Publications

Multi-ancestry genome-wide gene-smoking interaction study of 387,272 individuals identifies new loci associated with serum lipids.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets